Quarterly Snapshot: Quick and Current Ratios for SELLAS Life Sciences Group Inc (SLS)

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In other words, the price has increased by $0.00 from its previous closing price. On the day, 1.67 million shares were traded. SLS stock price reached its highest trading level at $1.375 during the session, while it also had its lowest trading level at $1.27.

Ratios:

Our analysis of SLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.26 and its Current Ratio is at 2.26. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 21, 2021, initiated with a Overweight rating and assigned the stock a target price of $18.

On April 02, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 02, 2018, with a $11 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLS now has a Market Capitalization of 90792776 and an Enterprise Value of 73247272.

Stock Price History:

Over the past 52 weeks, SLS has reached a high of $1.72, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 4.64%, while the 200-Day Moving Average is calculated to be 5.21%.

Shares Statistics:

SLS traded an average of 577.83K shares per day over the past three months and 873140 shares per day over the past ten days. A total of 70.38M shares are outstanding, with a floating share count of 70.08M. Insiders hold about 0.43% of the company’s shares, while institutions hold 7.63% stake in the company. Shares short for SLS as of 1730332800 were 8610940 with a Short Ratio of 14.90, compared to 1727654400 on 8176719. Therefore, it implies a Short% of Shares Outstanding of 8610940 and a Short% of Float of 13.41.

Earnings Estimates

The stock of SELLAS Life Sciences Group Inc (SLS) is currently being evaluated by 3.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.5 and low estimates of -$0.54.

Analysts are recommending an EPS of between -$0.42 and -$0.54 for the fiscal current year, implying an average EPS of -$0.47. EPS for the following year is $nan, with nan analysts recommending between $nan and $nan.

Revenue Estimates

Based on nan analysts’ estimates, the company’s revenue will be $nan in the next fiscal year. The high estimate is $nan and the low estimate is $nan.

Most Popular